Sarver Heart Cemter, Room 4137
Epigenetic Therapies for Heart Failure
Timothy A. McKinsey, PhD
Associate Professor and Associate Division Head for Translational Research
Director, Consortium for Fibrosis Research & Translation
Department of Medicine/Division of Cardiology
University of Colorado
Dr. McKinsey is Associate Professor and Associate Division Head for Translational Research in the Department of Medicine/Division of Cardiology at the University of Colorado Anschutz Medical Campus in Denver. He is also Director of the university’s newly formed Consortium for Fibrosis Research & Translation (CFReT; www.cfret.org). Prior to joining the university, Dr. McKinsey was Associate Director of Biology at Myogen/Gilead, where he was engaged in small molecule drug discovery for cardiovascular and pulmonary diseases.
Dr. McKinsey grew up in Springfield, Missouri, USA, and received a BS in Biology from the University of Missouri in Columbia. He obtained a PhD in Microbiology and Immunology from Vanderbilt University School of Medicine, where he studied NF-kB signaling in the laboratory of Dr. Dean Ballard. Dr. McKinsey’s postdoctoral training was done in the laboratory of Dr. Eric Olson at the University of Texas Southwestern Medical Center in Dallas, where he studied transcriptional control of muscle development and growth.